Advertisement
Screener

MeiraGTx Holdings plc (MGTX) Increase (Decrease) in Other Current Assets

2.8 / 5 stars · 68/120 Roast Me

MeiraGTx Holdings plc Increase (Decrease) in Other Current Assets

MeiraGTx Holdings plc (MGTX) reported Increase (Decrease) in Other Current Assets of $25.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-13

  • MeiraGTx Holdings plc increase (decrease) in other current assets for the quarter ending 2026-06-30 was $24.90M, a 20311.48% increase year-over-year.
  • MeiraGTx Holdings plc increase (decrease) in other current assets for the quarter ending 2026-03-31 was $113.00K.
  • MeiraGTx Holdings plc increase (decrease) in other current assets for the quarter ending 2025-12-31 was $2.29M, a 28.87% decline year-over-year.
  • MeiraGTx Holdings plc increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$413.00K.
  • MeiraGTx Holdings plc increase (decrease) in other current assets for fiscal 2025 was $365.00K, a 84.14% decline from fiscal 2024.
  • MeiraGTx Holdings plc increase (decrease) in other current assets for fiscal 2024 was $2.30M.
  • MeiraGTx Holdings plc increase (decrease) in other current assets for fiscal 2023 was -$222.00K.
  • MeiraGTx Holdings plc increase (decrease) in other current assets for fiscal 2022 was -$519.00K.
Period endIncrease (Decrease) in Other Current Assets 3 monthIncrease (Decrease) in Other Current Assets 3 month as first filedIncrease (Decrease) in Other Current Assets 6 monthIncrease (Decrease) in Other Current Assets 6 month as first filedIncrease (Decrease) in Other Current Assets 9 monthIncrease (Decrease) in Other Current Assets 9 month as first filedIncrease (Decrease) in Other Current Assets 12 monthIncrease (Decrease) in Other Current Assets 12 month as first filed
2026-06-30$24.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$25.02M
10-Q · filed 2026-08-13
$27.31M
derived: sum of 3 quarters · filed 2026-08-13
$26.90M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$113.00K
10-Q · filed 2026-05-14
$2.41M
derived: sum of 2 quarters · filed 2026-05-14
$1.99M
derived: sum of 3 quarters · filed 2026-05-14
$2.12M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$1.88M
derived: sum of 2 quarters · filed 2026-03-30
$2.00M
derived: sum of 3 quarters · filed 2026-08-13
$365.00K
10-K · filed 2026-03-30
2025-09-30-$413.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$291.00K
derived: sum of 2 quarters · filed 2026-08-13
-$1.93M
10-Q · filed 2025-11-13
$1.30M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$122.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$1.52M
10-Q · filed 2026-08-13
-$1.39M
10-Q · filed 2025-08-14
$1.71M
derived: sum of 3 quarters · filed 2026-08-13
$1.69M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$1.64M
10-Q · filed 2026-05-14
$1.59M
derived: sum of 2 quarters · filed 2026-05-14
$1.57M
derived: sum of 3 quarters · filed 2026-05-14
$1.29M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$3.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$3.21M
derived: sum of 2 quarters · filed 2026-03-30
$2.93M
derived: sum of 3 quarters · filed 2026-03-30
$2.30M
10-K · filed 2026-03-30
2024-09-30-$18.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$297.00K
derived: sum of 2 quarters · filed 2025-11-13
-$923.00K
10-Q · filed 2025-11-13
-$247.00K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$279.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$905.00K
10-Q · filed 2025-08-14
-$229.00K
derived: sum of 3 quarters · filed 2025-08-14
-$931.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$626.00K
10-Q · filed 2025-05-13
$50.00K
derived: sum of 2 quarters · filed 2025-05-13
-$652.00K
derived: sum of 3 quarters · filed 2025-05-13
-$712.00K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$676.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
-$26.00K
derived: sum of 2 quarters · filed 2025-03-13
-$86.00K
derived: sum of 3 quarters · filed 2025-03-13
-$222.00K
10-K · filed 2025-03-13
2023-09-30-$702.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
-$762.00K
derived: sum of 2 quarters · filed 2024-11-13
-$898.00K
10-Q · filed 2024-11-13
-$839.00K
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$60.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
-$196.00K
10-Q · filed 2024-08-12
-$137.00K
derived: sum of 3 quarters · filed 2024-08-12
-$1.81M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$136.00K
10-Q · filed 2024-05-09
-$77.00K
derived: sum of 2 quarters · filed 2024-05-09
-$1.75M
derived: sum of 3 quarters · filed 2024-05-09
-$268.00K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$59.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
-$1.61M
derived: sum of 2 quarters · filed 2024-03-15
-$132.00K
derived: sum of 3 quarters · filed 2024-03-15
-$519.00K
10-K · filed 2024-03-15
2022-09-30-$1.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$191.00K
derived: sum of 2 quarters · filed 2023-11-14
-$578.00K
10-Q · filed 2023-11-14
-$352.00K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$1.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$1.10M
10-Q · filed 2022-08-11
$1.32M
derived: sum of 3 quarters · filed 2022-08-11
$1.10M
derived: sum of 4 quarters · filed 2022-08-11
2022-03-31-$387.00K
10-Q · filed 2022-05-12
-$161.00K
derived: sum of 2 quarters · filed 2022-05-12
-$385.00K
derived: sum of 3 quarters · filed 2022-05-12
-$2.90M
derived: sum of 4 quarters · filed 2022-08-11
2021-12-31$226.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$2.00K
derived: sum of 2 quarters · filed 2022-03-10
-$2.51M
derived: sum of 3 quarters · filed 2022-08-11
-$2.16M
10-K · filed 2022-03-10
2021-09-30-$224.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
-$2.73M
derived: sum of 2 quarters · filed 2022-08-11
-$2.39M
10-Q · filed 2021-11-10
$1.24M
derived: sum of 4 quarters · filed 2022-08-11
2021-06-30-$2.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$2.16M
10-Q · filed 2022-08-11
$1.46M
derived: sum of 3 quarters · filed 2022-08-11
$347.00K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$348.00K
10-Q · filed 2022-05-12
$3.97M
derived: sum of 2 quarters · filed 2022-05-12
$2.86M
derived: sum of 3 quarters · filed 2022-05-12
$2.77M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$3.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$2.51M
derived: sum of 2 quarters · filed 2022-03-10
$2.42M
derived: sum of 3 quarters · filed 2022-03-10
$2.52M
10-K · filed 2022-03-10
$2.52M
10-K · filed 2021-03-11
2020-09-30-$1.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
-$1.21M
derived: sum of 2 quarters · filed 2021-11-10
-$1.11M
10-Q · filed 2021-11-10
-$1.11M
10-Q · filed 2020-11-05
-$7.29M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$89.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$10.00K
10-Q · filed 2021-08-11
$10.05K
10-Q · filed 2020-08-06
-$6.17M
derived: sum of 3 quarters · filed 2021-08-11
-$402.35K
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$99.00K
10-Q · filed 2021-05-11
$98.80K
10-Q · filed 2020-05-07
-$6.08M
derived: sum of 2 quarters · filed 2021-05-11
-$313.35K
derived: sum of 3 quarters · filed 2021-05-11
$2.80M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31-$6.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
-$412.35K
derived: sum of 2 quarters · filed 2021-03-11
$2.70M
derived: sum of 3 quarters · filed 2021-03-11
$178.81K
10-K · filed 2021-03-11
2019-09-30$5.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$8.88M
derived: sum of 2 quarters · filed 2020-11-05
$6.36M
10-Q · filed 2020-11-05
$6.78M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$3.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$591.15K
10-Q · filed 2020-08-06
$1.01M
derived: sum of 3 quarters · filed 2020-08-06
$1.42M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$2.52M
10-Q · filed 2020-05-07
-$2.10M
derived: sum of 2 quarters · filed 2020-05-07
-$1.69M
derived: sum of 3 quarters · filed 2020-05-07
-$2.19M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$421.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
$832.30K
derived: sum of 2 quarters · filed 2020-03-11
$335.55K
derived: sum of 3 quarters · filed 2020-03-11
$181.77K
10-K · filed 2020-03-11
$3.68M
10-K · filed 2019-03-26
2018-09-30$410.90K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$85.85K
derived: sum of 2 quarters · filed 2019-11-07
-$239.63K
10-Q · filed 2019-11-07
-$705.77K
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$496.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$650.53K
10-Q · filed 2019-08-07
-$1.12M
derived: sum of 3 quarters · filed 2019-08-07
-$897.08K
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31-$153.77K
10-Q · filed 2019-05-14
-$619.91K
derived: sum of 2 quarters · filed 2019-05-14
-$400.33K
derived: sum of 3 quarters · filed 2019-05-14
2017-12-31-$466.14K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
-$246.55K
derived: sum of 2 quarters · filed 2019-03-26
$493.42K
10-K · filed 2019-03-26
2017-09-30$219.59K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$959.57K
10-Q · filed 2018-11-08
2017-06-30$739.98K
10-Q · filed 2018-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10